MarketCapTrends
TCRT

Alaunos Therapeutics Inc.

NASDAQ · Healthcare

Alaunos Therapeutics Inc. annual/quarterly revenue history and growth rate from 2011 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

  • Alaunos Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 0, a 100.00% decrease year-over-year.
  • Alaunos Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 2000, a 60.00% decrease year-over-year.
  • Alaunos Therapeutics Inc. annual revenue for 2025 was 5000, a 50.00% decrease from 2024.
  • Alaunos Therapeutics Inc. annual revenue for 2024 was 10000, a 100.00% increase from 2023.
  • Alaunos Therapeutics Inc. annual revenue for 2023 was 5000, a 99.83% decrease from 2022.
  • Alaunos Therapeutics Inc. annual revenue for 2022 was 2.9 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %